1/13
Vocabulary review flashcards covering causes, manifestations, diagnostic calculations, and clinical management priorities for Diabetic Ketoacidosis (DKA) and Hyperosmolar Hyperglycemic State (HHS).
Diabetic Ketoacidosis (DKA) Etiology
Caused by insulin deficiency, which triggers lipolysis and ketone production.
DKA Acidosis
Metabolic acidosis caused by the accumulation of acidic ketone bodies.
Kussmaul Respirations
Deep, rapid breathing changes that serve as a hallmark clinical sign of DKA.
Fruity Acetone Breath
A characteristic breath odor that may occur in patients presenting with DKA.
Hyperosmolar Hyperglycemic State (HHS)
A metabolic crisis characterized by severe hyperglycemia and dehydration with minimal ketosis.
Type 2 Diabetes
The diabetes type that is commonly associated with HHS.
HHS Dehydration
The hyperglycemic crisis that typically presents with greater dehydration compared to DKA.
First Major Treatment Priority (DKA/HHS)
Restoring circulation with appropriate IV fluids.
Regular Insulin
The specific form of insulin used in IV infusions for treating DKA and HHS.
Pre-Insulin Potassium Check
A necessary assessment before administering insulin, because insulin shifts potassium into cells and risks causing hypokalemia.
Potassium Safety Threshold
A K level below approximately ∼3.3−3.5, at which insulin administration should be delayed until potassium is replaced.
Dextrose Administration in DKA
An intervention added during DKA treatment to allow continued insulin administration to clear ketosis while avoiding hypoglycemia.
Anion Gap
A calculated laboratory value determined by subtracting chloride plus bicarbonate from sodium: Sodium−(Chloride+Bicarbonate).
DKA/HHS Treatment Monitoring Parameters
The vital clinical markers that must be monitored during treatment: glucose, potassium, fluid status, neurologic status, and acid-base.